Abstract
A series of novel benzimidazole derivatives were synthesized and evaluated for their anti-hepatitis B virus (HBV) activity and cytotoxicity in the HepG2.2.15 cell line. The preliminary SAR was discussed. Compound 12a, with IC 50 <0.41 μM and SI >81.2, was the most promising compound and selected as the benchmark compound for further optimization.
| Original language | English |
|---|---|
| Pages (from-to) | 5048-5055 |
| Number of pages | 8 |
| Journal | Bioorganic and Medicinal Chemistry |
| Volume | 18 |
| Issue number | 14 |
| DOIs | |
| State | Published - 15 Jul 2010 |
Keywords
- Anti-HBV activity
- Benzimidazoles